Brazil-Italy joint lab focuses on Alzheimer’s drug development

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease.

Pharmalittle: We’re reading about Ozempic and an eye condition, a failed Roche cancer drug trial, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

July 5, 2024

What Is Tianeptine and Why Is It in Demand?

An uptick in adverse events connected to unregulated tianeptine products — often referred to as “gas station heroin” — along with the voluntary recall of

February 2, 2024

Docs’ Vacation Habits May Be Fueling Burnout

Taking fewer vacation days and working during vacation time were associated with higher rates of burnout among physicians, according to a cross-sectional study. In a

January 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.